This phase 1/2 trial tests the safety and effectiveness of a cancer vaccine called Labvax 3(22)-23 and GM-CSF alone or in combination with pembrolizumab in tre…

Advanced AdenocarcinomaAdvanced Malignant Solid NeoplasmMetastatic Adenocarcinoma+3 more

~Estimated

~$10 – $7,500

Tianhong LiNCT05101356

A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

To evaluate the performance characteristics of Signal-C™ a plasma circulating free-DNA test, to detect colorectal cancer and advanced precancerous lesions (APL…

Colorectal CancerAdvanced Adenocarcinoma

~Estimated

~$10 – $1,050

Universal DiagnosticsNCT06059963

Phase 1

An Open-label, Multicenter, Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Efficacy of BA3182, a Bispecific Epithelial Cell Adhesion Molecule (EpCAM)/CD3 Antibody, in Patients With Advanced Adenocarcinoma

The objective of this study is to assess safety and efficacy of BA3182 in Advanced Adenocarcinoma

Advanced Adenocarcinoma

~Estimated

~$10 – $8,750

BioAtla, Inc.NCT05808634